← Back to Search

Behavioural Intervention

Evaluation of Body Composition Improvement With Visceral Adiposity-Focused Anti-Obesity Telehealth Program

N/A
Recruiting
Led By Jessica Barnes, PhD
Research Sponsored by 20Lighter
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Men and women 18 years of age and older, who enroll in the weight loss program are eligible for inclusion of the data review.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 90 days
Awards & highlights
No Placebo-Only Group

Summary

A retrospective review of body composition changes in patients who participate in a 9-week non-invasive intensive health care provider supervised weight loss program as an overall cohort and in sub-cohorts of interest.

Eligible Conditions
  • Obesity
  • Metabolic Syndrome
  • Cardiovascular Disease
  • Metabolic Diseases

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body Fat % Change
Body Mass Index (BMI) Change
Bodyweight Change
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Program participantsExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

20LighterLead Sponsor
1 Previous Clinical Trials
2,200 Total Patients Enrolled
1 Trials studying Obesity
2,200 Patients Enrolled for Obesity
Jessica Barnes, PhDPrincipal Investigator20Lighter
1 Previous Clinical Trials
2,200 Total Patients Enrolled
1 Trials studying Obesity
2,200 Patients Enrolled for Obesity
~333 spots leftby Jan 2026